Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto’s thyroiditis in a patient after allogenic bone marrow transplantation

Ikue Okamura-ShikiDivision of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan;

Michihisa MoriguchiDivision of Interventional Radiology, Shizuoka Cancer Center, Shizuoka, Japan; ;Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan;

Tokiko UeharaDivision of Internal Medicine of Endocrinology and Metabolism, Atami Hospital, International University of Health and Welfare, Shizuoka, Japan;

Masafumi FukayaDivision of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan;

Yuko KakudaDivision of Pathology, Shizuoka Cancer Center, Shizuoka, Japan

Yasuni NakanumaDivision of Pathology, Shizuoka Cancer Center, Shizuoka, Japan

Takashi IkedaDivision of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan; Correspondence[email protected]

show all

Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto’s thyroiditis in a patient after allogenic bone marrow transplantation

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto’s thyroiditis in a patient after allogenic bone marrow transplantation

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date